South Korea · Delayed Price · Currency is KRW CORESTEMCHEMON Statistics
Total Valuation
CORESTEMCHEMON has a market cap or net worth of KRW 101.36 billion. The enterprise value is 134.58 billion.
| Market Cap | 101.36B |
| Enterprise Value | 134.58B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CORESTEMCHEMON has 44.36 million shares outstanding. The number of shares has increased by 61.89% in one year.
| Current Share Class | 44.36M |
| Shares Outstanding | 44.36M |
| Shares Change (YoY) | +61.89% |
| Shares Change (QoQ) | +1.44% |
| Owned by Insiders (%) | 11.51% |
| Owned by Institutions (%) | 0.12% |
| Float | 39.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.54 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.27, with a Debt / Equity ratio of 0.85.
| Current Ratio | 0.27 |
| Quick Ratio | 0.12 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.31 |
| Interest Coverage | -24.06 |
Financial Efficiency
Return on equity (ROE) is -61.95% and return on invested capital (ROIC) is -26.05%.
| Return on Equity (ROE) | -61.95% |
| Return on Assets (ROA) | -11.97% |
| Return on Invested Capital (ROIC) | -26.05% |
| Return on Capital Employed (ROCE) | -33.94% |
| Weighted Average Cost of Capital (WACC) | 9.98% |
| Revenue Per Employee | 508.11M |
| Profits Per Employee | -772.41M |
| Employee Count | 36 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 109.64 |
Taxes
| Income Tax | -26.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.91% in the last 52 weeks. The beta is 1.59, so CORESTEMCHEMON's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -0.91% |
| 50-Day Moving Average | 2,008.64 |
| 200-Day Moving Average | 2,452.33 |
| Relative Strength Index (RSI) | 62.07 |
| Average Volume (20 Days) | 100,903 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CORESTEMCHEMON had revenue of KRW 18.29 billion and -27.81 billion in losses. Loss per share was -681.81.
| Revenue | 18.29B |
| Gross Profit | -4.90B |
| Operating Income | -20.89B |
| Pretax Income | -27.83B |
| Net Income | -27.81B |
| EBITDA | -17.01B |
| EBIT | -20.89B |
| Loss Per Share | -681.81 |
Balance Sheet
The company has 4.44 billion in cash and 37.65 billion in debt, with a net cash position of -33.21 billion or -748.74 per share.
| Cash & Cash Equivalents | 4.44B |
| Total Debt | 37.65B |
| Net Cash | -33.21B |
| Net Cash Per Share | -748.74 |
| Equity (Book Value) | 44.40B |
| Book Value Per Share | 917.52 |
| Working Capital | -31.15B |
Cash Flow
In the last 12 months, operating cash flow was -10.01 billion and capital expenditures -1.38 billion, giving a free cash flow of -11.39 billion.
| Operating Cash Flow | -10.01B |
| Capital Expenditures | -1.38B |
| Depreciation & Amortization | 3.88B |
| Net Borrowing | -18.19B |
| Free Cash Flow | -11.39B |
| FCF Per Share | -256.74 |
Margins
Gross margin is -26.80%, with operating and profit margins of -114.18% and -152.02%.
| Gross Margin | -26.80% |
| Operating Margin | -114.18% |
| Pretax Margin | -152.16% |
| Profit Margin | -152.02% |
| EBITDA Margin | -92.97% |
| EBIT Margin | -114.18% |
| FCF Margin | n/a |
Dividends & Yields
CORESTEMCHEMON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.89% |
| Shareholder Yield | -61.89% |
| Earnings Yield | -27.43% |
| FCF Yield | -11.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CORESTEMCHEMON has an Altman Z-Score of -1.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.67 |
| Piotroski F-Score | 2 |